Your browser is no longer supported. Please, upgrade your browser.
DSCI Derma Sciences, Inc. daily Stock Chart
DSCI [NASD]
Derma Sciences, Inc.
Index- P/E- EPS (ttm)-0.31 Insider Own6.26% Shs Outstand28.17M Perf Week0.36%
Market Cap197.19M Forward P/E- EPS next Y-0.11 Insider Trans0.00% Shs Float26.28M Perf Month0.36%
Income-8.20M PEG- EPS next Q-0.04 Inst Own58.90% Short Float0.51% Perf Quarter59.09%
Sales88.60M P/S2.23 EPS this Y6.70% Inst Trans-1.13% Short Ratio0.30 Perf Half Y38.89%
Book/sh4.13 P/B1.69 EPS next Y-10.00% ROA-2.20% Target Price7.00 Perf Year114.07%
Cash/sh1.46 P/C4.81 EPS next 5Y- ROE-2.80% 52W Range2.92 - 7.05 Perf YTD34.62%
Dividend- P/FCF- EPS past 5Y-15.40% ROI-20.00% 52W High-0.71% Beta0.98
Dividend %- Quick Ratio1.00 Sales past 5Y8.40% Gross Margin41.10% 52W Low139.72% ATR0.06
Employees260 Current Ratio1.30 Sales Q/Q22.50% Oper. Margin-14.90% RSI (14)71.55 Volatility0.97% 0.83%
OptionableYes Debt/Eq0.00 EPS Q/Q7.30% Profit Margin-3.30% Rel Volume0.13 Prev Close7.00
ShortableYes LT Debt/Eq0.00 EarningsMar 15 BMO Payout- Avg Volume443.02K Price7.00
Recom3.00 SMA200.18% SMA5012.26% SMA20042.66% Volume0 Change0.00%
Jan-18-17Downgrade ROTH Capital Buy → Neutral
Jan-08-16Reiterated Oppenheimer Outperform $8 → $7
Dec-03-15Reiterated ROTH Capital Buy $16 → $9.50
Nov-13-15Reiterated Piper Jaffray Neutral $6 → $4
Nov-13-15Reiterated Oppenheimer Outperform $17 → $8
Aug-14-14Reiterated Oppenheimer Outperform $19 → $18
Mar-17-14Reiterated Oppenheimer Outperform $19 → $21
Jul-06-11Initiated Oppenheimer Outperform $21
Feb-09-11Reiterated Rodman & Renshaw Mkt Outperform $13 → $25
May-14-10Initiated Rodman & Renshaw Mkt Outperform $13
Feb-24-17 08:31AM  DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or F
Feb-23-17 08:30AM  Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc. GlobeNewswire
Feb-15-17 09:15AM  Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion
Jan-27-17 11:22AM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders Business Wire
Jan-25-17 05:01PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
08:30AM  Integra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. GlobeNewswire
Jan-23-17 03:21PM  Were in the year of the biotech buyout, and here are five prime targets at MarketWatch
Jan-20-17 06:35PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. - DSCI Accesswire
Jan-18-17 09:36AM  Derma Sciences downgraded by ROTH Capital
Jan-17-17 09:00PM  INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Shareholders To Contact The Firm For Additional Information Business Wire
05:26PM  Harwood Feffer LLP Announces Investigation of Derma Sciences Inc. PR Newswire
04:38PM  DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen
11:13AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders -- DSCI PR Newswire
Jan-13-17 06:35PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. -DSCI PR Newswire
05:06PM  DERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Derma Sciences, Inc. (DSCI) Over the Proposed Sale of the Company to Integra LifeSciences Holdings Corporation PR Newswire
Jan-12-17 08:00PM  SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Investors To Contact The Firm For Additional Information Business Wire
12:50PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders Business Wire
11:15AM  Integra LifeSciences Buys Derma Sciences for $204M at Investopedia
11:11AM  DERMA SCIENCES, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Integra LifeSciences Holdings Corporation May be Unfair to Shareholders Business Wire
10:10AM  Company News for January 12, 2017
08:15AM  Blog Coverage Integra Set to Acquire Derma Sciences; Announced Outlook 2017 Accesswire
Jan-11-17 04:15PM  Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner Business Wire +39.00%
03:22PM  Wednesdays Top Biopharma Movers
01:02PM  Derma Sciences Soars Almost 40% on Buyout by Integra
12:44PM  ETFs with exposure to Derma Sciences, Inc. : January 11, 2017
11:05AM  DERMA SCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
10:02AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders - DSCI Accesswire
09:33AM  DERMA (DSCI) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Derma Sciences, Inc.; Is $7 a Fair Price? PR Newswire
07:42AM  Integra LifeSciences at 52-Week High on Deals, View Update
Jan-10-17 08:00PM  Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook GlobeNewswire
08:00PM  Derma Sciences to Be Acquired by Integra LifeSciences for $7.00 Per Share of Common Stock in Cash Business Wire
Jan-09-17 06:00AM  Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan GlobeNewswire
Dec-16-16 01:35PM  ETFs with exposure to Derma Sciences, Inc. : December 16, 2016
Dec-09-16 02:36PM  Derma Sciences Inc (DSCI): Smart Money Continues to Abandon the Stock at Insider Monkey +7.78%
Nov-30-16 12:15PM  ETFs with exposure to Derma Sciences, Inc. : November 30, 2016
Nov-28-16 10:48AM  Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
Nov-17-16 01:04PM  DERMA SCIENCES, INC. Financials
Nov-14-16 10:00AM  Edited Transcript of DSCI earnings conference call or presentation 10-Nov-16 4:00pm GMT
Nov-10-16 04:00PM  Derma Sciences to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:45AM  Derma Sciences reports 3Q loss
07:30AM  Derma Sciences Reports 2016 Third Quarter Financial Results Business Wire
07:07AM  Q3 2016 Derma Sciences Inc Earnings Release - Before Market Open
Nov-09-16 05:24PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-02-16 04:00PM  Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th Business Wire
Oct-21-16 05:23PM  DERMA SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
Oct-05-16 10:16AM  ETFs with exposure to Derma Sciences, Inc. : October 5, 2016
Sep-26-16 09:04AM  Henry Schein (HSIC) Grows Through Acquisitions, Runs Risks
Sep-23-16 08:43AM  Medtronic (MDT): Valiant Captivia Data Positive at Three Years
08:38AM  LabCorp: Strong Fundamentals, Sequenom Buyout Raise Hope
Sep-21-16 02:02PM  Derma Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference Business Wire
Sep-08-16 05:10PM  DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and
Sep-01-16 04:05PM  Derma Sciences Completes the Sale of Its First Aid Products Division Business Wire
Aug-30-16 08:50AM  Others Overlooked Derma Sciences (DSCI), Should You Buy It Now?
Aug-26-16 04:31PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.60%
Aug-25-16 05:26PM  LabCorp's Takeover of Sequenom Wins Antitrust Clearance
07:30AM  Derma Sciences Receives Reimbursement Coding for New MEDIHONEY® Hydrogel Dressings Business Wire
Aug-24-16 04:05PM  Derma Sciences AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor NGS Business Wire
Aug-18-16 01:52PM  Edited Transcript of DSCI earnings conference call or presentation 9-Aug-16 3:00pm GMT
07:30AM  Derma Sciences Names Russell Olsen President of Advanced Wound Care Business Wire
Aug-17-16 01:10PM  ETFs with exposure to Derma Sciences, Inc. : August 17, 2016
Aug-15-16 01:50PM  Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-11-16 05:11PM  DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equ
07:17AM  New Strong Buy Stocks for August 11th
Aug-09-16 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
08:42AM  Derma Sciences posts 2Q profit
07:30AM  Derma Sciences Reports 2016 Second Quarter Financial Results Business Wire
07:07AM  Q2 2016 Derma Sciences Inc Earnings Release - Before Market Open
Aug-08-16 05:26PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Aug-03-16 09:13AM  Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th Business Wire +5.44%
Aug-01-16 06:06AM  DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
Jul-29-16 08:08AM  Term Sheet Friday, July 29 at Fortune
Jul-28-16 07:30AM  Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products Business Wire +12.53%
Jul-27-16 07:30AM  Derma Sciences to Sell First Aid Products Division for Approximately $12.2 Million Business Wire +6.16%
Jul-20-16 12:20PM  ETFs with exposure to Derma Sciences, Inc. : July 20, 2016
Jul-08-16 08:59AM  Becton, Dickinson (BDX) at 52-Week High on New Launches
08:54AM  Halyard Health Now a Strong Buy, Portfolio Key Catalyst
Jul-05-16 09:29AM  CR Bard: Expansion Plans on Track, Product Pipeline Strong
Jun-03-16 04:43PM  DERMA SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-24-16 08:35AM  Why Derma Sciences (DSCI) Could Be Positioned for a Surge
May-23-16 12:29PM  Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
May-19-16 08:56AM  Can The Uptrend Continue for Derma Sciences (DSCI)?
May-11-16 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:37AM  Derma Sciences reports 1Q loss
07:30AM  Derma Sciences Reports 2016 First Quarter Financial Results Business Wire
May-10-16 05:21PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report +6.38%
May-06-16 02:31PM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11th Business Wire
Apr-27-16 07:30AM  Derma Sciences Announces AMNIOEXCEL® Is Now Eligible for Reimbursement by Medicare Administrative Contractor CGS Business Wire
Apr-04-16 01:59PM  Edited Transcript of DSCI earnings conference call or presentation 16-Mar-16 3:00pm GMT
Mar-16-16 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
08:30AM  Medical Products Companies Tap Into $50 Billion U.S. Government GSA Supply Program Accesswire
07:49AM  Derma Sciences reports 4Q loss
07:30AM  Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial Results Business Wire
07:07AM  Q4 2015 Derma Sciences Inc Earnings Release - Before Market Open
Mar-15-16 05:18PM  DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report
Mar-10-16 09:52AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 16th Business Wire
Mar-07-16 07:30AM  Findings from Multicenter Study Comparing Derma Sciences AMNIOEXCEL® Against Standard-of-Care for Treating Diabetic Foot Ulcers Published in WOUNDS, a Leading Peer-Reviewed Journal Business Wire +7.52%
Mar-03-16 09:50AM  STAAR Surgical Posts Break-Even Q4 Earnings, Sales Rise
08:30AM  Derma Sciences AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor WPS Business Wire
Mar-01-16 06:16AM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Derma Sciences, Inc. operates as a medical device company in the wound care market. Its Advanced Wound Care segment offers MEDIHONEY dressings for managing non-chronic and hard-to-heal wounds, including chronic ulcers, burns, and post-operative wounds; TCC-EZ system for patients with diabetic foot ulcers; AMNIOEXCEL for tissue repair, reconstruction, and replacement; and AMNIOMATRIX that is used as a wound covering in the treatment of localized tissue defects. This segment also provides XTRASORB dressings, which convert fluid within the dressings to a gel and lock the exudates into the dressings; BIOGUARD dressings for prophylactic use in the prevention of hospital or community acquired infections through wound sites; ALGICELL AG antimicrobial dressings; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and DERMAGRAN products. The company's Traditional Wound Care segment offers gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices; adhesive bandages and related first aid products; private-label wound care products; wound closure strips, nasal tube fasteners, and catheter fasteners; and general purpose and specialized skin care products. Derma Sciences, Inc. markets its products to acute care, extended care, home health care, nursing homes, hospitals, wound and burn care clinics and physician offices through direct sales force, independent distributors, and manufacturers' representatives. The company was founded in 1984 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eigner FredericExecutive VP - OperationsFeb 10Option Exercise6.409,37560,00060,199Feb 16 07:24 PM
YETTER JOHN EEVP, Finance & CFOFeb 10Option Exercise6.409,37560,00067,394Feb 16 07:22 PM
COLE ROBERT CSee RemarksFeb 10Option Exercise6.409,37560,00080,711Feb 16 07:20 PM
CONJEEVARAM SRINIDirectorFeb 10Option Exercise6.404,37528,00085,817Feb 16 07:17 PM
WILLS STEPHEN TExecutive ChairmanFeb 10Option Exercise6.404,37528,000151,076Feb 16 07:15 PM
MOUSSA ROBERT GDirectorFeb 10Option Exercise6.404,37528,00085,771Feb 16 07:13 PM